Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Hospital La Paz, Madrid, Spain.
Clin Nutr ESPEN. 2024 Aug;62:247-252. doi: 10.1016/j.clnesp.2024.05.025. Epub 2024 Jun 3.
To report the results and successes of intestinal transplantation (ITx) in the most active European centres, to emphasize that, although it is a difficult procedure, it should remain a therapeutic option for children with total, definitive and complicated intestinal failure when intestinal rehabilitation fails.
We retrospectively collected data about all patients less than 18 receiving an ITx from 2010 to 2022 in 8 centres, and outcomes in July 2022.
ITx was performed in 155 patients, median age 6.9 years, in 45% for short bowel syndromes, 22% congenital enteropathies, 25% motility disorders, and 15% re-transplantations. Indications were multiple in most patients, intestinal failure-associated liver disease in half. The graft was in 70% liver-containing. At last follow up 64% were alive, weaned from parenteral nutrition, for 7.9 years; 27% had died and the graft was removed in 8%, mostly early after ITx.
ITx, despite its difficulties, can give a future to children with complicated intestinal failure. It should be considered among the therapeutic options offered to patients with a predicted survival rate lower than that after ITx. Patients should be early discussed within multidisciplinary teams in ITx centres, to avoid severe complications impacting the results of ITx, or even to avoid ITx.
报告欧洲最活跃中心的肠移植(ITx)的结果和成功,强调尽管这是一项困难的手术,但当肠道康复失败时,对于患有完全、明确和复杂肠道衰竭的儿童,它仍然应该是一种治疗选择。
我们回顾性地收集了 2010 年至 2022 年 8 个中心的 155 名年龄均小于 18 岁接受 ITx 的患者的数据,并在 2022 年 7 月获得了结果。
ITx 应用于 155 名患者,中位年龄为 6.9 岁,45%的患者患有短肠综合征,22%的患者患有先天性肠病,25%的患者患有运动障碍,15%的患者为再次移植。大多数患者的适应症是多种的,一半的患者有肠衰竭相关肝病。移植物中有 70%含有肝脏。在最后一次随访时,64%的患者存活,已脱离肠外营养,随访时间为 7.9 年;27%的患者死亡,8%的患者移植物被移除,大部分发生在 ITx 后早期。
尽管 ITx 存在困难,但它可以为患有复杂肠道衰竭的儿童带来未来。对于预计生存率低于 ITx 后生存率的患者,应将其视为提供的治疗选择之一。患者应在 ITx 中心的多学科团队中尽早讨论,以避免严重并发症影响 ITx 的结果,甚至避免 ITx。